Investigational Drug Information for Oltipraz
✉ Email this page to a colleague
What is the drug development status for Oltipraz?
Oltipraz is an investigational drug.
There have been 5 clinical trials for Oltipraz.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 15th 2019.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Liver Diseases, and Fatty Liver. The leading clinical trial sponsors are PharmaKing, National Cancer Institute (NCI), and Northwestern University.
There are four hundred and forty-four US patents protecting this investigational drug and zero international patents.
Summary for Oltipraz
| US Patents | 444 |
| International Patents | 4,941 |
| US Patent Applications | 1,505 |
| WIPO Patent Applications | 698 |
| Japanese Patent Applications | 267 |
| Clinical Trial Progress | Phase 3 (2019-11-15) |
| Vendors | 60 |
Recent Clinical Trials for Oltipraz
| Title | Sponsor | Phase |
|---|---|---|
| Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis | PharmaKing | Phase 3 |
| Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis | PharmaKing | Phase 3 |
| Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease | PharmaKing | Phase 2 |
Clinical Trial Summary for Oltipraz
Top disease conditions for Oltipraz
Top clinical trial sponsors for Oltipraz
US Patents for Oltipraz
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Oltipraz | ⤷ Sign Up | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases | Halozyme, Inc. (San Diego, CA) | ⤷ Sign Up |
| Oltipraz | ⤷ Sign Up | Pyrazolopyrimidine compounds | GLAXOSMITHKLINE LLC (Wilmington, DE) | ⤷ Sign Up |
| Oltipraz | ⤷ Sign Up | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | vTv Therapeutics LLC (High Point, NC) | ⤷ Sign Up |
| Oltipraz | ⤷ Sign Up | Methods for the prevention and the treatment of rapidly progressive glomerulonephritis | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS DESCARTES (Paris, FR) | ⤷ Sign Up |
| Oltipraz | ⤷ Sign Up | Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE) | ⤷ Sign Up |
| Oltipraz | ⤷ Sign Up | Bicyclic compound, production and use thereof | TOBIRA THERAPEUTICS, INC. (South San Francisco, CA) | ⤷ Sign Up |
| Oltipraz | ⤷ Sign Up | Anthelmintic compounds | MERIAL INC. (Duluth, GA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Oltipraz
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Oltipraz | Austria | AT448323 | 2023-03-05 | ⤷ Sign Up |
| Oltipraz | Australia | AU2004218354 | 2023-03-05 | ⤷ Sign Up |
| Oltipraz | Australia | AU2006216545 | 2023-03-05 | ⤷ Sign Up |
| Oltipraz | Australia | AU2009245838 | 2023-03-05 | ⤷ Sign Up |
| Oltipraz | Australia | AU2013202475 | 2023-03-05 | ⤷ Sign Up |
| Oltipraz | Brazil | BRPI0408116 | 2023-03-05 | ⤷ Sign Up |
| Oltipraz | Brazil | BRPI0608314 | 2023-03-05 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
